Home›Search›Pharmaceutical Patent Analyst

Pharmaceutical Patent Analyst

Taylor and Francis Ltd. · United Kingdom · Est. 1993

ISSN2046-8954

SJR Q3✓ Scopus / SJR

/ 100

High Risk

Score Breakdown

✓ Scopus Q3+12

Total22

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Score

0.3

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.304

Total Works

552

Total Citations

3,342

2yr Mean Citedness

1.29

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

The Pharmaceutical Patent Analyst focuses on recent developments in pharmaceutical and medical research and development, as evidenced by patent literature. It covers therapeutic agents, drug discovery, and treatment methods for various diseases, including cancer, neurodegenerative disorders, and infectious diseases. The journal also examines patent landscapes, regulatory considerations, and legal aspects related to drug development and approval, such as obviousness-type double patenting and the approval process for novel therapeutic modalities like PROTACs and bispecific antibodies.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 75% in field

General Information

Country / RegionUnited Kingdom

Primary Language—

1st Year Published1993

Annual Volume~ 27 articles / year

StatusActive (last: 2024)

Total Publications552

Publisher OrgFuture Science Ltd

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/12 · 42%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2046-8954

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2017

2018

2019

2020

2021

2022

2023

2024

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q3

Pharmaceutical ScienceQ3

Drug DiscoveryQ4

Subject Classification

Scopus Categories

Drug DiscoveryPharmaceutical ScienceMedicine (miscellaneous)

Research Topics (OpenAlex)

Intellectual Property and PatentsPharmaceutical Economics and PolicyBiomedical Ethics and RegulationHealth Systems, Economic Evaluations, Quality of LifeBiosimilars and Bioanalytical MethodsPharmaceutical studies and practicesCancer Research and TreatmentsBiotechnology and Related FieldsComputational Drug Discovery MethodsUbiquitin and proteasome pathways